Articles

Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome

Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Biomedical Sciences, Humanitas University and Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano-Milano
Department of Hematology, ASST Spedali Civili di Brescia
Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Hematology, ASST Spedali Civili di Brescia
Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano-Milano
Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Pathology, ASST Spedali Civili di Brescia
Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Pathology, IRCCS Humanitas Research Hospital, Rozzano-Milano
Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Hematology, Ospedale San Gerardo, Monza
Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori
Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano-Milano
Department of Hematology, ASST Spedali Civili di Brescia
Department of Biomedical Sciences, Humanitas University and Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano-Milano
Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; Chair of Hematology University of Milano
Haematologica Early view Jul 22, 2021 https://doi.org/10.3324/haematol.2021.278638